FDMT R&D Expenses
4D Molecular Therapeutics Inc · R&D Expenses
FDMT R&D Expenses
Latest reported$68.28Mperiod ending
FDMT Quarterly R&D Expenses ($4.10M → $68.28M)
Quarterly R&D Expenses
High-resolution chart · PNG
FDMT r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 68,282,000 | |
| 64,980,000 | |
| 57,608,000 | |
| 49,438,000 | |
| 47,951,000 | |
| 40,699,000 | |
| 43,085,000 | |
| 38,484,000 | |
| 31,860,000 | |
| 27,870,000 | |
| 26,028,000 | |
| 25,066,000 | |
| 23,584,000 | |
| 22,412,000 | |
| 21,500,000 | |
| 18,940,000 | |
| 20,422,000 | |
| 19,381,000 | |
| 17,528,000 | |
| 15,840,000 | |
| 15,223,000 | |
| 12,769,000 | |
| 12,605,000 | |
| 11,555,000 | |
| 15,720,000 | |
| 13,158,000 | |
| 12,359,000 | |
| 9,374,000 | |
| 8,492,500 | |
| 8,492,500 | |
| 5,077,000 | |
| 5,077,000 | |
| 4,104,000 | |
| 4,104,000 |